| 1 |
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Alessandro Gronchi et al. · Journal of Clinical Oncology
Open access |
18 May 2020 |
264 |
| 2 |
Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial
Sandro Pasquali et al. · Cancer
Open access |
13 Oct 2021 |
108 |
| 3 |
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group
Giovanni Grignani et al. · The Lancet Oncology
Open access |
11 Sep 2018 |
96 |
| 4 |
Parosteal osteosarcoma: a monocentric retrospective analysis of 195 patients
Poosit Ruengwanichayakun, Marco Gambarotti, Tommaso Frisoni et al. · Human Pathology
|
23 May 2019 |
41 |
| 5 |
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series
Emanuela Palmerini, Elisabetta Setola, Giovanni Grignani et al. · Cells
Open access |
31 Oct 2020 |
36 |
| 6 |
Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group
Anna Paioli, Silvia Stacchiotti, Domenico Andrea Campanacci et al. · Annals of Surgical Oncology
|
22 Jun 2020 |
36 |
| 7 |
Phase 2 study for nonmetastatic extremity high‐grade osteosarcoma in pediatric and adolescent and young adult patients with a risk‐adapted strategy based on ABCB1/P‐glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS‐2)
Emanuela Palmerini et al. · Cancer
Open access |
24 Feb 2022 |
35 |
| 8 |
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
Ivar Hompland et al. · European Journal of Cancer
Open access |
11 May 2021 |
34 |
| 9 |
Lung metastasectomy for osteosarcoma in children, adolescents, and young adults: proof of permanent cure
Ugo Pastorino, Emanuela Palmerini, Luca Porcu et al. · Tumori Journal
Open access |
21 Oct 2021 |
31 |
| 10 |
ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas
Miriam Michiko Wilhelm, Uta Dirksen, Stefan S. Bielack et al. · Annals of Oncology
Open access |
25 Jun 2014 |
30 |
| 11 |
How Does the Skeletal Oncology Research Group Algorithm’s Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
Michiel E. R. Bongers, Aditya V. Karhade, Elisabetta Setola et al. · Clinical Orthopaedics and Related Research
Open access |
18 May 2020 |
23 |
| 12 |
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group
Emanuela Palmerini et al. · Cancers
Open access |
2 Mar 2021 |
21 |
| 13 |
Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bone: A retrospective analysis of available scoring tools
Alberto Righi, Marina Pacheco, Emanuela Palmerini et al. · European Journal of Surgical Oncology
|
17 Feb 2021 |
15 |
| 14 |
Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study
Sebastian Dorin Asaftei et al. · Cancers
Open access |
18 Jun 2021 |
14 |
| 15 |
New European Clinical Trial Regulation: perception and expectations in Italy
Celeste Cagnazzo, Sara Campora, E. Ferretti et al. · Annals of Oncology
Open access |
28 Mar 2017 |
11 |
| 16 |
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study
Massimo Eraldo Abate et al. · Cancers
Open access |
3 Jun 2021 |
10 |
| 17 |
Epidemiology of Bone Lesions
Piero Picci
Book chapter |
6 Dec 2019 |
9 |
| 18 |
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis
Emanuela Palmerini et al. · Frontiers in Oncology
Open access |
8 Dec 2022 |
8 |
| 19 |
New requirements for phase I trials: a challenge for Italian clinical research
Emanuela Marchesi, Manuela Monti, Oriana Nanni et al. · Tumori Journal
|
11 Aug 2017 |
8 |
| 20 |
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence
Lorenzo D’Ambrosio et al. · JAMA Network Open
Open access |
6 Nov 2023 |
7 |
| 21 |
How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience
Emanuela Marchesi, Celeste Cagnazzo, Irene Quattrini et al. · Clinical Sarcoma Research
Open access |
15 Feb 2017 |
7 |
| 22 |
Epidemiology of Soft Tissue Lesions
Piero Picci
Book chapter |
6 Dec 2019 |
5 |
| 23 |
1625MO ABCB1/P-glycoprotein (Pgp) expression as stratification factor for treatment of patients with non metastatic extremity high grade osteosarcoma: An Italian Sarcoma Group (ISG) multicentric prospective trial (ISG/OS-2)
Emanuela Palmerini, Cristina Meazza, A. Tamburini et al. · Annals of Oncology
Open access |
Sep 2020 |
2 |
| 24 |
Classification of Primary Bone Lesions
Piero Picci, Marco Gambarotti, Alberto Righi
Book chapter |
6 Dec 2019 |
2 |
| 25 |
The impact of the new European CTR on academic clinical research: A survey by the Italian Sarcoma Group Federated Trial Centre
Viviana Appolloni, Gianluca Ignazzi, Daniela Salvatore et al. · Tumori Journal
|
10 Apr 2025 |
1 |
| 26 |
Fibrous Dysplasia
Piero Picci
Book chapter |
6 Dec 2019 |
1 |
| 27 |
Staging
Piero Picci
Book chapter |
6 Dec 2019 |
1 |
| 28 |
Nerve Sheath Tumor
Piero Picci, Angelo Paolo Dei Tos
Book chapter |
6 Dec 2019 |
1 |
| 29 |
AIFA Determination 809/2015 on Phase I Clinical Trials: a new challenge for Italian Research
Emanuela Marchesi, Manlio Monti, Sara Campora et al. · Annals of Oncology
Open access |
Sep 2016 |
1 |
| 30 |
STARS (NCT 07265661): Surgical timing after preoperative hypofractionated radiotherapy for patients with primary localized soft tissue sarcoma of the extremity and trunk—A randomized phase 2 clinical trial.
Marco Baia, Alessandro Gronchi, Claudia Sangalli et al. · Journal of Clinical Oncology
|
28 May 2026 |
0 |
| 31 |
Sacral chordoma: A randomized and observational study on surgery vs definitive particle-based radiotherapy in primary localized disease (SACRO)
Piero Fossati, Stefano Radaelli, Eugen B. Hug et al. · International Journal of Particle Therapy
Open access |
24 Mar 2026 |
0 |
| 32 |
Non-profit research: an insight into the management and monitoring of clinical trials in Italy
Fatima Tizi, Viviana Appolloni, Barbara Bonifacio et al. · Global & Regional Health Technology Assessment
Open access |
13 Mar 2026 |
0 |
| 33 |
Sacral Chordoma: A Randomized and Observational Study on Surgery vs. Definitive Radiotherapy in Primary Localized Disease (SACRO)
Patrick Fossati et al. · International Journal of Radiation Oncology*Biology*Physics
Open access |
Sep 2025 |
0 |
| 34 |
The new European Clinical Trial Regulation: Perception and expectations in Italy
C. Cagnazzo, S. Campora, F. Arizio et al. · Annals of Oncology
Open access |
Oct 2016 |
0 |
| 35 |
Osteosarcomas (OS)
Piero Picci
Book chapter |
6 Dec 2019 |
0 |
| 36 |
Fibroblastic/Myofibroblastic Tumors
Piero Picci, Angelo Paolo Dei Tos, Marco Gambarotti et al.
Book chapter |
6 Dec 2019 |
0 |
| 37 |
Smooth and Striated Muscle
Piero Picci, Angelo Paolo Dei Tos
Book chapter |
6 Dec 2019 |
0 |
| 38 |
P3.07-018 New European Clinical Trial Regulation: What's Going On?
Celeste Cagnazzo, Sara Campora, Francesca Arizio et al. · Journal of Thoracic Oncology
Open access |
2017 |
0 |